Mosbrooker Eric Insider Trades

Insider Trading History

Track insider trading activity for Mosbrooker Eric. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $677k 55,000 shares
Last Trade
Oct 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$298k 6,562 shares
$45.38
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $2.18M 177,188 shares
Last Trade
Oct 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$308k 6,562 shares
$46.97
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $757k 61,562 shares
Last Trade
Oct 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$308k 6,562 shares
$46.97
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $757k 61,563 shares
Last Trade
Sep 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$312k 6,563 shares
$47.59
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $677k 55,000 shares
Last Trade
Sep 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$309k 6,563 shares
$47.07
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $2.26M 183,750 shares
Last Trade
Sep 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$312k 6,563 shares
$47.59
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $2.29M 185,807 shares
Last Trade
Aug 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.02M 124,687 shares
$48.26
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $752k 61,120 shares
Last Trade
Aug 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.76M 130,807 shares
$44.06
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $2.34M 190,313 shares
Last Trade
Aug 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.02M 124,687 shares
$48.26
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $444k 36,120 shares
Last Trade
Jan 06, 2025 Sale
$9.9M 315,000 shares
$31.42
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Chief Commercial Officer
Holding Value $752k 61,120 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57M 50,000 shares
$31.42
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $271k 22,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 22,000 shares
$12.48
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $271k 22,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 22,000 shares
$12.03
$12.30
Avidity Biosciences
Avidity Biosciences RNA
Director
Holding Value $369k 30,000 shares
Last Trade
Aug 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$625k 30,000 shares
$20.83
$12.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Svp, Orphan Business Unit
Holding Value $1.55M 13,306 shares
Last Trade
Nov 01, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$61.3k 4,435 shares
$13.83
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Svp, Orphan Business Unit
Holding Value $417k 3,585 shares
Last Trade
Nov 01, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$32k 2,315 shares
$13.83
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Svp, Orphan Business Unit
Holding Value $686k 5,900 shares
Last Trade
Nov 01, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$61.3k 4,435 shares
$13.83
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Svp, Orphan Business Unit
Holding Value $170k 1,465 shares
Last Trade
Aug 23, 2017 Sale
$477k 35,733 shares
$13.36
$116.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up